It has been reported that HLA-A*03:01 confers susceptibility to MS independent of HLA class II risk alleles (39); the HLA-C*03:01:01:01 allele is carried by a third of the RE cases in our study cohort. The gene discussed is HLA-C; the disease is myeloid sarcoma.